Curis Lifesciences Ltd
✓Strengths
- Comfortable interest cover: operating profit covers interest about 9.9 times.
- Net profit margin is strong at 15.1%.
- Promoters hold a majority stake (68.03%).
!Watch-points
No notable watch-points flagged by the automated checks.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 160 Cr
Current Price—
High / Low₹ 229.00 / 83.60
Stock P/E29.90
Book Value—
Dividend Yield0.00%
ROCE—
ROE—
Face Value₹ 10.00
Debt to Equity—
PEG Ratio0.09
EV / EBITDA17.54
Industry PE35.70
P/B Ratio—
EPS₹ 107.20
Debt—
PAT Margin15.06%
Cash PAT₹ 6 Cr
ICR9.93
Promoter Holding68.03%
FII Holding1.19%
DII Holding5.80%
Public Holding24.98%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).